Rethinking Diabetes Treatment: Gary Taubes Shares Life-Changing Insights! 🤯
What this video covers
A webinar hosted by Dr. Peter Brukner of Defeat Diabetes Australia, built around Taubes’s 2024 book Rethinking Diabetes. The conversation is structured as a 150-year history of diabetes treatment: before insulin’s discovery, physicians managed diabetes with carbohydrate-restricted diets; after insulin arrived in the 1920s, dietary therapy was gradually abandoned in favor of drug therapy — a shift Taubes treats as one of medicine’s great wrong turns.
Taubes walks through the milestones: the emergence of insulin therapy, the evolution of drug treatments, the chronic complications that persisted despite better drugs, and studies like Look AHEAD that tested whether lifestyle intervention could change outcomes. He and Brukner debate the central question of glucose versus insulin — which is the bigger enemy — and Taubes argues that the field’s fixation on blood sugar (glucose) while tolerating ever-higher insulin levels has been a conceptual error. The conversation also covers the grassroots, patient-driven low-carb movement and the resistance it has met from the medical establishment, closing on a note of what the video describes as “cynicism and hope.”
Key points
- Taubes argues that diabetes was once managed successfully with diet alone, and that insulin’s discovery — while life-saving for type 1 diabetes — led the field to abandon dietary therapy for type 2.
- He contends the shift from diet to drugs was a philosophical change, not one driven by evidence that drugs outperformed diet.
- A central claim: medicine has focused on glucose while ignoring insulin, and Taubes argues hyperinsulinemia itself may be the more important problem.
- He discusses the Look AHEAD study as an example of how lifestyle-intervention research has been designed and interpreted within the drug-centered paradigm.
- Taubes describes a “stickiness of beliefs” — institutional resistance to reconsidering dietary therapy even as patient-led low-carb movements report remissions.
- The lifestyle-versus-medication debate is presented through patient stories and transformations, which Taubes treats as evidence the establishment dismisses too readily.
- He credits the patient-driven movement: at Duke, Eric Westman’s turning point was a patient who did exactly the opposite of what he was told — lived on steak and eggs, lost weight, and tested healthier — prompting Westman to say “I don’t believe what I’m seeing. I’m going to study it,” and run the clinical trial that confirmed it. In the UK, David Unwin was “about to retire, hating medicine,” until one patient on a low-carb diet changed his whole attitude.
- Taubes is withering about the nutrition establishment’s latest pivot — telling people not to eat “ultra-processed foods” without defining the term — calling it the abandonment of science altogether after decades of reductionism about macronutrients.
- Note the framing: the host organization runs a low-carb diabetes program, so the conversation is sympathetic throughout; the “debate” is largely about how right the low-carb position is, not whether it is.